id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-D-0369-0459,FDA,FDA-2007-D-0369,"Product-Specific Guidance for Linaclotide; Draft Guidance for
Industry",Notice,Notice of Availability,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,2019-02-27T04:59:59Z,2019-02-27T02:04:39Z,2018-28213,0,0,09000064839cbf71
FDA-2007-D-0369-0456,FDA,FDA-2007-D-0369,"Product-Specific Guidances; Draft and Revised Draft Guidances for Industry;
Availability",Notice,Notice of Availability,2018-11-29T05:00:00Z,2018,11,2018-11-29T05:00:00Z,2019-01-29T04:59:59Z,2024-11-12T22:50:12Z,2018-25950,1,0,090000648390c07a
FDA-2007-D-0369-0451,FDA,FDA-2007-D-0369,"Product-Specific Guidance; Revised Draft Guidance for Industry on
Sucralfate; Reopening of Comment Period",Notice,Request for Comments,2018-10-26T04:00:00Z,2018,10,2018-10-26T04:00:00Z,2018-12-27T04:59:59Z,2024-11-07T01:05:30Z,2018-23386,1,0,09000064838556fe
FDA-2007-D-0369-0450,FDA,FDA-2007-D-0369,"Product-Specific Guidances; Draft and Revised Draft Guidances for Industry;
Availability",Notice,Notice of Availability,2018-10-10T04:00:00Z,2018,10,2018-10-10T04:00:00Z,2018-12-11T04:59:59Z,2018-11-16T02:02:06Z,2018-21957,0,0,09000064837b545e
FDA-2007-D-0369-0444,FDA,FDA-2007-D-0369,"Product-Specific Guidances; Draft and Revised Draft Guidances for Industry;
Availability",Notice,Notice of Availability,2018-09-14T04:00:00Z,2018,9,2018-09-14T04:00:00Z,2018-11-14T04:59:59Z,2018-11-14T02:07:13Z,2018-20018,0,0,09000064836ed340
FDA-2007-D-0369-0441,FDA,FDA-2007-D-0369,Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,Notice,Notice of Availability,2018-07-23T04:00:00Z,2018,7,2018-07-23T04:00:00Z,2018-09-22T03:59:59Z,2024-11-07T23:53:58Z,2018-15735,1,0,09000064835362a4
FDA-2007-D-0369-0438,FDA,FDA-2007-D-0369,Product-Specific Guidance for Doxycycline Hyclate; Revised Draft Guidance for Industry; Availability,Notice,Notice of Availability,2018-03-29T04:00:00Z,2018,3,2018-03-29T04:00:00Z,2018-05-30T03:59:59Z,2018-03-29T13:40:58Z,2018-06253,0,0,0900006483061a7c
FDA-2007-D-0369-0436,FDA,FDA-2007-D-0369,"Product-Specific Guidances; Draft and Revised Draft Guidances for Industry;
Availability",Notice,Notice of Availability,2018-02-09T05:00:00Z,2018,2,2018-02-09T05:00:00Z,2018-04-11T03:59:59Z,2018-04-04T01:01:57Z,2018-02667,0,0,0900006482f05fa5